0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±¸°­°ü¸® ÇÁ·ÎÅäÄÝ Àû¿ëÀÌ Ç×¾ÏÈ­Çпä¹ýÀ» ¹Þ´Â Ç÷¾×¾Ï ȯÀÚÀÇ Ç÷¾×¾Ï ȯÀÚÀÇ ±¸³»¿°¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of Oral Care Protocol on Oral Mucositis in Hematologic Malignancy Patients Receiving Chemotherapy

ÀÓ»ó°£È£¿¬±¸ 2016³â 22±Ç 1È£ p.1 ~ 9
KMID : 1004620160220010001
¹Ú¼öÁø:Park Soo-Jin
Â÷°æ¼÷:Cha Kyung-Suk/±èÇü¼±:Kim Hyeung-Sun/¹ÚÀº¿µ:Park Eun-Young

Abstract

Purpose: This study was done to identify effects of oral care protocol on oralmucositis and oral care performance in hematologic malignancy patients receiving chemotherapy.

Methods: The design of this study was a nonequivalent control group pretest-posttest design. Both groups were patients diagnosed with hematologic malignancies who were receiving chemotherapy-each group had 20 patients. In the experimental group, patients were given intensive education on oral care based on the oral care protocol, whereas in the controlled group, each patient was given an educational brochure. Before chemotherapy, and 3 days, 7 days, and 14 days
after chemotherapy, oral mucositis status of two groups were assessed using the guide to physical assessment
of the oral cavity. Oral care performance was examined before chemotherapy and 14 days later.

Results: The experimental group with the oral care protocol showed a significant difference (F=18.15, p<.001) in the oral mucositis status, and also in oral care performance (t=-10.33, p<.001).

Conclusion: Findings indicate that the application of the oral care protocol is an effective tool for lowering the occurrence of oral mucositis and enhancing oral care performance in hematologic malignancy patients receiving chemotherapy.
KeyWords
±¸°­°ü¸®ÇÁ·ÎÅäÄÝ, ±¸³»¿°, Ç×¾ÏÈ­Çпä¹ý, Ç÷¾×¾Ï
Mucositis, Practice Guideline, Chemotherapeutic Agents, Hematologic Neoplasm
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI)